Expertise in
5
conditions

Tim U. Magnus

Hamburg, HH, DE 
Expertise in
5
conditions
Hamburg, HH, DE 

Overview

Tim Magnus practices practicing medicine in Hamburg, Germany.

Mr. Magnus is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Stroke, Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, Thrombectomy, and Deep Brain Stimulation.

He is actively involved in clinical research, co-authoring 173 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hamburg, HH, Germany
Other Locations
Eppendorf, HH 20246, Germany
Munich, BY, Germany
Wuerzburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

173 Total Publications

Neurotransmitter-Informed Connectome Approach to Language Impairment After Stroke.
Neurotransmitter-Informed Connectome Approach to Language Impairment After Stroke.
Journal: Stroke
Published: June 12, 2026

Frequently Asked Questions about Tim U. Magnus

Is Tim U. Magnus a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Tim U. Magnus is classified as an Advanced expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tim U. Magnus participate in research or clinical trials?

Yes. Tim U. Magnus has published 173 articles and abstracts on conditions like Stroke. You can view a list of Tim U. Magnus's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Magnus's expertise for a condition
ConditionClose
      View All 34 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile